NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Adenocarcinoma



Reports from J.P. Geisler and co-researchers add new data to research in adenocarcinoma



April 29th, 2008

"The purpose of this study was to analyze estrogen receptor alpha and beta (ER alpha, ER beta) expression in a stage and grade matched cohort of patients with serous and endometrioid adenocarcinoma of the ovary. Forty-two patients from 1991 to the present were found to have the diagnosis of endometrioid adenocarcinoma of the ovary and have tissue available for analysis," scientists in the United States report.

"Of these 42, ten were selected for analysis. These were stage and grade matched with ten patients having serous adenocarcinoma of the ovary during the same time period. ER alpha and ER beta mRNA was detected by a multiplex RT-PCR and amplification of random...


Source: Cancer Weekly (2008-04-29)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login